Venrock Healthcare Capital Partners Discloses 5.3% Stake in Erasca, Inc. (ERAS)

On May 15, 2026, a group of reporting persons led by Venrock Healthcare Capital Partners III, L.P. filed a Schedule 13G/A disclosing a 5.3% stake in Erasca, Inc. (ERAS). The reporting group, which includes VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P., and managing members Nimish Shah and Bong Koh, reported aggregate beneficial ownership of 16,382,812 shares of common stock. This filing represents a significant increase from the previously reported 0.0% ownership, establishing a new major position for the Venrock entities. The shares are held across multiple funds: 2,676,745 shares by VHCP III, 267,632 shares by VHCP Co-Investment III, and 13,438,435 shares by VHCP EG. The reporting persons share voting and dispositive power over these securities. The percentage of ownership is based on approximately 310.8 million shares outstanding as of March 31, 2026. The filing was made pursuant to Rule 13d-1(c), indicating a passive investment intent.